scholarly article | Q13442814 |
P2093 | author name string | Ueda M | |
Hatanaka M | |||
Maki M | |||
Hamaguchi K | |||
Murachi T | |||
Bagci H | |||
P433 | issue | 32 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | calpastatin peptide Ac 184-210 | Q27225287 |
P304 | page(s) | 18866-18869 | |
P577 | publication date | 1989-11-01 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Inhibition of calpain by a synthetic oligopeptide corresponding to an exon of the human calpastatin gene | |
P478 | volume | 264 |
Q41891517 | Binding‐induced folding transitions in calpastatin subdomains A and C |
Q39630331 | Calcium-induced cleavage of DNA topoisomerase I involves the cytoplasmic-nuclear shuttling of calpain 2. |
Q42214621 | Calpain activity is generally elevated during transformation but has oncogene-specific biological functions |
Q33963936 | Calpain and PARP activation during photoreceptor cell death in P23H and S334ter rhodopsin mutant rats |
Q37502232 | Calpain and the glutamatergic synapse |
Q39661641 | Calpain inhibitors reduce retinal hypoxia in ischemic retinopathy by improving neovascular architecture and functional perfusion |
Q48305515 | Calpain regulation of AMPA receptor channels in cortical pyramidal neurons |
Q35906413 | Cathepsin L Mediates the Degradation of Novel APP C-Terminal Fragments. |
Q42986389 | Decreased susceptibility to calpains of v-FosFBR but not of v-FosFBJ or v-JunASV17 retroviral proteins compared with their cellular counterparts. |
Q41081671 | Degradation of the proto-oncogene product p39mos is not necessary for cyclin proteolysis and exit from meiotic metaphase: requirement for a Ca(2+)-calmodulin dependent event |
Q39214141 | Endothelial cell calpain as a critical modulator of angiogenesis |
Q36989525 | HER2 regulates Brk/PTK6 stability via upregulating calpastatin, an inhibitor of calpain |
Q33755662 | Homology modeling study of bovine μ-calpain inhibitor-binding domains. |
Q30497248 | Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax. |
Q37307187 | Inhibition of calpain blocks platelet secretion, aggregation, and spreading |
Q34238103 | Moderation of calpain activity promotes neovascular integration and lumen formation during VEGF-induced pathological angiogenesis |
Q30979050 | NMR relaxation studies on the hydrate layer of intrinsically unstructured proteins |
Q35063603 | Nanomedicine strategies for treatment of secondary spinal cord injury |
Q42980526 | PEST motifs are not required for rapid calpain-mediated proteolysis of c-fos protein |
Q36568304 | Proteolysis by calpains: a possible contribution to degradation of p53. |
Q36517553 | Role of calpain in skeletal-muscle protein degradation |
Q44940750 | The effects of calpain inhibition on IkB alpha degradation after activation of PBMCs: identification of the calpain cleavage sites |
Q42995469 | The sensitivity of c-Jun and c-Fos proteins to calpains depends on conformational determinants of the monomers and not on formation of dimers |
Search more.